These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 21492964
1. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Gilley J, Seereeram A, Ando K, Mosely S, Andrews S, Kerschensteiner M, Misgeld T, Brion JP, Anderton B, Hanger DP, Coleman MP. Neurobiol Aging; 2012 Mar; 33(3):621.e1-621.e15. PubMed ID: 21492964 [Abstract] [Full Text] [Related]
9. Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei. Dutschmann M, Menuet C, Stettner GM, Gestreau C, Borghgraef P, Devijver H, Gielis L, Hilaire G, Van Leuven F. J Neurosci; 2010 Feb 03; 30(5):1810-21. PubMed ID: 20130190 [Abstract] [Full Text] [Related]
10. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, Guimaraes A, Yue M, Lewis J, Carlson G, Hutton M, Ashe KH. J Neurosci; 2005 Nov 16; 25(46):10637-47. PubMed ID: 16291936 [Abstract] [Full Text] [Related]
11. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy. Koller EJ, Gonzalez De La Cruz E, Machula T, Ibanez KR, Lin WL, Williams T, Riffe CJ, Ryu D, Strang KH, Liu X, Janus C, Golde TE, Dickson D, Giasson BI, Chakrabarty P. Hum Mol Genet; 2019 Oct 01; 28(19):3255-3269. PubMed ID: 31261380 [Abstract] [Full Text] [Related]
12. In vivo axonal transport deficits in a mouse model of fronto-temporal dementia. Majid T, Ali YO, Venkitaramani DV, Jang MK, Lu HC, Pautler RG. Neuroimage Clin; 2014 Oct 01; 4():711-7. PubMed ID: 24936422 [Abstract] [Full Text] [Related]
14. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. Boekhoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ, de Vos K, Krugers H, Tomiyama T, Mori H, Joels M, van Leuven F, Lucassen PJ. J Neurosci; 2006 Mar 29; 26(13):3514-23. PubMed ID: 16571759 [Abstract] [Full Text] [Related]
15. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model. Zhang B, Yao Y, Cornec AS, Oukoloff K, James MJ, Koivula P, Trojanowski JQ, Smith AB, Lee VM, Ballatore C, Brunden KR. Mol Neurodegener; 2018 Nov 07; 13(1):59. PubMed ID: 30404654 [Abstract] [Full Text] [Related]
19. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy. Javidnia M, Hebron ML, Xin Y, Kinney NG, Moussa CE. J Alzheimers Dis; 2017 Jan 07; 60(2):461-481. PubMed ID: 28869476 [Abstract] [Full Text] [Related]
20. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy. Takaichi Y, Ano Y, Chambers JK, Uchida K, Takashima A, Nakayama H. J Neuropathol Exp Neurol; 2018 Oct 01; 77(10):920-928. PubMed ID: 30107539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]